163 related articles for article (PubMed ID: 23808401)
1. Template for reporting results of biomarker testing of specimens from patients with non-small cell carcinoma of the lung.
Cagle PT; Sholl LM; Lindeman NI; Alsabeh R; Divaris DX; Foulis P; Lee G; Neal JW; Nowak JA; Yu PP;
Arch Pathol Lab Med; 2014 Feb; 138(2):171-4. PubMed ID: 23808401
[No Abstract] [Full Text] [Related]
2. Template for reporting results of biomarker testing of specimens from patients with carcinoma of the colon and rectum.
Bartley AN; Hamilton SR; Alsabeh R; Ambinder EP; Berman M; Collins E; Fitzgibbons PL; Gress DM; Nowak JA; Samowitz WS; Zafar SY;
Arch Pathol Lab Med; 2014 Feb; 138(2):166-70. PubMed ID: 23808403
[No Abstract] [Full Text] [Related]
3. Lung Carcinoma Predictive Biomarker Testing by Immunoperoxidase Stains in Cytology and Small Biopsy Specimens: Advantages and Limitations.
Zhou F; Moreira AL
Arch Pathol Lab Med; 2016 Dec; 140(12):1331-1337. PubMed ID: 27588333
[TBL] [Abstract][Full Text] [Related]
4. Introducing new College of American Pathologists reporting templates for cancer biomarkers.
Fitzgibbons PL; Lazar AJ; Spencer S
Arch Pathol Lab Med; 2014 Feb; 138(2):157-8. PubMed ID: 23808404
[No Abstract] [Full Text] [Related]
5. [New perspectives in the management of non-small-cell lung carcinoma (NSCLC)].
Brockmöller J; Junker K; Multhoff G
Onkologie; 2006 Sep; 29 Suppl 2():25-8. PubMed ID: 16974125
[No Abstract] [Full Text] [Related]
6. Genes and pathology of non-small cell lung carcinoma.
Sakashita S; Sakashita M; Sound Tsao M
Semin Oncol; 2014 Feb; 41(1):28-39. PubMed ID: 24565579
[TBL] [Abstract][Full Text] [Related]
7. [Small biopsies and cytologic specimens management in microscopic diagnosis and subtyping of non-small cell lung cancer, as recommended by IASLC/ATS/ERS].
Langfort R; Szołkowska M; Szczepulska-Wójcik E; Maksymiuk B
Pneumonol Alergol Pol; 2012; 80(2):172-7. PubMed ID: 22370987
[No Abstract] [Full Text] [Related]
8. Lung cancer biomarkers: present status and future developments.
Cagle PT; Allen TC; Olsen RJ
Arch Pathol Lab Med; 2013 Sep; 137(9):1191-8. PubMed ID: 23991729
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical detection of nuclear survivin in NSCLC: a comparison of commercial antibodies.
Vischioni B; Oudejans JJ; Kruyt FA; Giaccone G; Rodriguez JA
Histopathology; 2007 Apr; 50(5):671-5. PubMed ID: 17394508
[No Abstract] [Full Text] [Related]
10. Emerging gene mutation targets in lung cancer.
Johnson BE
Clin Adv Hematol Oncol; 2015 Dec; 13(12):812-4. PubMed ID: 27058846
[No Abstract] [Full Text] [Related]
11. SSX2-4 expression in early-stage non-small cell lung cancer.
Greve KB; Pøhl M; Olsen KE; Nielsen O; Ditzel HJ; Gjerstorff MF
Tissue Antigens; 2014 May; 83(5):344-9. PubMed ID: 24645645
[TBL] [Abstract][Full Text] [Related]
12. Biomarker testing in non-small cell lung cancer: a clinician's perspective.
Bernicker E
Arch Pathol Lab Med; 2015 Apr; 139(4):448-50. PubMed ID: 25166873
[No Abstract] [Full Text] [Related]
13. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
[TBL] [Abstract][Full Text] [Related]
14. Characterization of periostin isoform pattern in non-small cell lung cancer.
Morra L; Rechsteiner M; Casagrande S; von Teichman A; Schraml P; Moch H; Soltermann A
Lung Cancer; 2012 May; 76(2):183-90. PubMed ID: 22079858
[TBL] [Abstract][Full Text] [Related]
15. Comparison of reverse transcription-polymerase chain reaction, immunohistochemistry, and fluorescence in situ hybridization methodologies for detection of echinoderm microtubule-associated proteinlike 4-anaplastic lymphoma kinase fusion-positive non-small cell lung carcinoma: implications for optimal clinical testing.
Wallander ML; Geiersbach KB; Tripp SR; Layfield LJ
Arch Pathol Lab Med; 2012 Jul; 136(7):796-803. PubMed ID: 22742552
[TBL] [Abstract][Full Text] [Related]
16. New method to identify non-small-cell lung cancer biomarker.
Hill R
Bioanalysis; 2013 Oct; 5(19):2337. PubMed ID: 24066618
[No Abstract] [Full Text] [Related]
17. [Comments on the guidelines of the French-Language Society of Pneumology on the use of serum tumor markers in the management of primary bronchial cancers. Restatement].
Roche N; Lioté H; Housset B
Rev Mal Respir; 1999 Dec; 16(6):1165-6. PubMed ID: 10637920
[No Abstract] [Full Text] [Related]
18. Identification and classification of differentially expressed genes in non-small cell lung cancer by expression profiling on a global human 59.620-element oligonucleotide array.
Hofmann HS; Bartling B; Simm A; Murray R; Aziz N; Hansen G; Silber RE; Burdach S
Oncol Rep; 2006 Sep; 16(3):587-95. PubMed ID: 16865260
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors in non-small cell lung carcinoma.
Koutsami MK; Gorgoulis VG; Kastrinakis NG; Asimacopoulos PJ; Kittas C
Anticancer Res; 2002; 22(1A):347-74. PubMed ID: 12017316
[TBL] [Abstract][Full Text] [Related]
20. Increased apolipoprotein E gene expression and protein concentration in lung cancer tissue do not contribute to the clinical assessment of non-small cell lung cancer patients.
Trost Z; Marc J; Sok M; Cerne D
Arch Med Res; 2008 Oct; 39(7):663-7. PubMed ID: 18760194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
